Status:
COMPLETED
Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer
Lead Sponsor:
All India Institute of Medical Sciences
Conditions:
Gallbladder Cancer
Obstructive Jaundice
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Cancer of the gallbladder (CaGB) is one of the most common causes of malignant obstructive jaundice. Jaundice is the second most common presentation and occurs in 30-60% of patients with CaGB. It is o...
Detailed Description
Hypothesis: Percutaneous biliary stenting is superior to endoscopic stenting in providing successful biliary drainage by 20% in patients with unresectable malignant hilar block due to carcinoma of gal...
Eligibility Criteria
Inclusion
- CaGB with hilar block not suitable for curative resection with one or more of the following criteria:
- Jaundice with serum bilirubin \>10 mg/dl,
- Pruritus,
- Cholangitis
Exclusion
- Poor performance status: Karnofsky index \< 60,
- Type 1 and 4 hilar block,
- Uncontrolled ascites,
- Duodenal obstruction,
- Patients who opted for insertion of a metallic stent.
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2005
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT00409864
Start Date
October 1 2003
End Date
December 1 2005
Last Update
May 26 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
All India Institute of Medical Sciences,
New Delhi, National Capital Territory of Delhi, India, 110029